GlobalData on MSN12h
EMA approves addition of sites to Greenwich LifeSciences’ breast cancer trialThe European Medicines Agency (EMA) has approved the expansion of Greenwich LifeSciences’ Phase III FLAMINGO-01 breast cancer ...
Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...
Washington Post staff tried to separate what is happening from what is not, and to explain what may happen in the future.
Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposiumEight abstracts discussing data and clinical ...
Jan. 22, 10:30 a.m. PST Cal Fire data marked the Palisades Fire at 68% containment and the Eaton Fire at 91% containment, ...
Clinical data management companies play a crucial role in the healthcare sector by ensuring the accurate collection, validation, and analysis of clinical trial data. Their work enhances research ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
"Influential people are once again twisting the truth about vaccines for their own gain," writes Eleanor Menzin.
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback